0001628280-23-041428.txt : 20231213 0001628280-23-041428.hdr.sgml : 20231213 20231213160016 ACCESSION NUMBER: 0001628280-23-041428 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231208 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231213 DATE AS OF CHANGE: 20231213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ChromaDex Corp. CENTRAL INDEX KEY: 0001386570 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 262940963 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37752 FILM NUMBER: 231483935 BUSINESS ADDRESS: STREET 1: 10900 WILSHIRE BLVD STREET 2: SUITE 600 CITY: LOS ANGELES STATE: CA ZIP: 90024 BUSINESS PHONE: 310-388-6706 MAIL ADDRESS: STREET 1: 10900 WILSHIRE BLVD STREET 2: SUITE 600 CITY: LOS ANGELES STATE: CA ZIP: 90024 FORMER COMPANY: FORMER CONFORMED NAME: CODY RESOURCES, INC. DATE OF NAME CHANGE: 20070112 8-K 1 cdxc-20231208.htm 8-K cdxc-20231208
0001386570FALSE00013865702023-12-082023-12-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 8, 2023

CHROMADEX CORPORATION
(Exact name of registrant as specified in its charter)

Delaware001-3775226-2940963
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

10900 Wilshire Blvd. Suite 600, Los Angeles, California 90024
(Address of principal executive offices, including zip code)

(310) 388-6706
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
CDXC
The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 1.01. Entry into a Material Definitive Agreement.

On December 8, 2023, ChromaDex Corporation (the “Company”), and the Company’s wholly owned subsidiaries, ChromaDex, Inc., a California corporation, and ChromaDex Analytics, Inc., a Nevada corporation (together with the Company, the “Borrowers”) entered into an amendment (the “Amendment”) to the business financing agreement (as amended, the “Credit Agreement”) dated November 1, 2019 among the Borrowers and Western Alliance Bank (the “Lender”).

The Credit Agreement provides for a revolving credit line of up to $10.0 million. The Amendment extended the maturity date of the revolving credit line under the Credit Agreement to November 12, 2025 and also increased the interest rate to be calculated at a floating rate per month equal to (a) the greater of (i) 8.25% per year (instead of 3.25% per year) or (ii) the Prime Rate published in the Money Rates section of the Western Edition of The Wall Street Journal, or such other rate of interest publicly announced by the Lender as its Prime Rate, plus (b) 1.00%, plus an additional 5.00% during any period that an event of default has occurred and is continuing. There are no amounts outstanding under the Credit Agreement, as amended, as of the date of this Current Report on Form 8-K. The maturity date of the Credit Agreement had previously been extended to December 12, 2023 pursuant to the amendment attached hereto as Exhibit 10.1.

In addition, the Amendment amends certain financial covenants, including (a) the amount of the Borrowers’ cash maintained at Lender (b) revising how quick ratio is calculated for purposes of the quick ratio covenant, and (c) Borrowers’ minimum liquidity requirements.

The foregoing is only a summary of the material terms of the Amendment, and does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.2 hereto.


Item 2.03. Creation of Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth under Item 1.01 above is hereby incorporated by reference into Item 2.03.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHROMADEX CORPORATION
Dated: December 13, 2023
By:/s/ BRIANNA L. GERBER
Brianna L. Gerber
Chief Financial Officer
(principal financial officer and duly authorized on behalf of the registrant)

EX-10.1 2 ex101-fourthmodificationto.htm EX-10.1 Document
EXHIBIT 10.1
FOURTH MODIFICATION TO BUSINESS FINANCING AGREEMENT
This Fourth Modification to Business Financing Agreement (this “Amendment”) is entered into as of November 9, 2023, by and among WESTERN ALLIANCE BANK, an Arizona corporation (“Lender”), CHROMADEX CORPORATION, a Delaware corporation, CHROMADEX, INC., a California corporation, and CHROMADEX ANALYTICS, INC., a Nevada corporation (individually and collectively, “Borrower”).
1.DESCRIPTION OF EXISTING INDEBTEDNESS: Among other indebtedness which may be owing by Borrower to Lender, Borrower is indebted to Lender pursuant to, among other documents, a Business Financing Agreement, dated November 12, 2019, by and among Borrower, HEALTHSPAN RESEARCH LLC, a Delaware limited liability company (“Released Borrower”) and Lender, as may be amended from time to time (the “Business Financing Agreement”). Pursuant to that certain Consent Agreement dated January 14, 2021, by and among Borrower, Lender, and Released Borrower, Released Borrower was released by Lender from its Obligations under the Business Financing Agreement and the other Loan Documents. Capitalized terms used without definition herein shall have the meanings assigned to them in the Business Financing Agreement.
Hereinafter, all indebtedness owing by Borrower to Lender shall be referred to as the “Indebtedness” and the Business Financing Agreement and any and all other documents executed by Borrower in favor of Lender shall be referred to as the “Existing Documents”.
2.DESCRIPTION OF CHANGE IN TERMS.
(a)Amended Defined Term. The following definition set forth in Section 13.1 of the Business Financing Agreement is hereby amended by deleting it in its entirety and replacing it with the following:
Maturity Date” means December 12, 2023, or such earlier date as Lender shall have declared the Obligations immediately due and payable pursuant to Section 7.2.
3.CONSISTENT CHANGES. The Existing Documents are each hereby amended wherever necessary to reflect the change described above.
4.NO DEFENSES OF BORROWER/GENERAL RELEASE. Borrower agrees that, as of this date, it has no defenses against the obligations to pay any amounts under the Indebtedness. Each Borrower (each, a “Releasing Party”) acknowledges that Lender would not enter into this Amendment without Releasing Party’s assurance that it has no claims against Lender or any of Lender’s officers, directors, employees or agents. Except for the obligations arising hereafter under this Amendment, each Releasing Party releases Lender, and each of Lender’s and entity’s officers, directors and employees from any known or unknown claims that Releasing Party now has against Lender of any nature, including any claims that Releasing Party, its successors, counsel, and advisors may in the future discover they would have now had if they had known facts not now known to them, whether founded in contract, in tort or pursuant to any other theory of liability, including but not limited to any claims arising out of or related to the Agreement or the transactions contemplated thereby. Releasing Party waives the provisions of California Civil Code section 1542, which states:
A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.
The provisions, waivers and releases set forth in this section are binding upon each Releasing Party and its shareholders, agents, employees, assigns and successors in interest. The provisions, waivers and releases of this section shall inure to the benefit of Lender and its agents, employees, officers, directors, assigns and successors in interest. The provisions of this section shall survive payment in full of the Obligations, full performance of all the terms of this Amendment and the Business Financing Agreement, and/or Lender’s actions to exercise any remedy available under the Business Financing Agreement or otherwise.
1


5.CONTINUING VALIDITY. Borrower understands and agrees that in modifying the existing Indebtedness, Lender is relying upon Borrower’s representations, warranties, and agreements, as set forth in the Existing Documents. Except as expressly modified pursuant to this Amendment, the terms of the Existing Documents remain unchanged and in full force and effect. Lender’s agreement to modifications to the existing Indebtedness pursuant to this Amendment in no way shall obligate Lender to make any future modifications to the Indebtedness. Nothing in this Amendment shall constitute a satisfaction of the Indebtedness. It is the intention of Lender and Borrower to retain as liable parties all makers and endorsers of Existing Documents, unless the party is expressly released by Lender in writing. No maker, endorser, or guarantor will be released by virtue of this Amendment. The terms of this paragraph apply not only to this Amendment, but also to any subsequent Business Financing Agreement modifications.
6.CONDITIONS PRECEDENT. The effectiveness of this Amendment is conditioned upon the due execution and delivery to Lender of this Amendment by each party hereto.
7.NOTICE OF FINAL AGREEMENT. BY SIGNING THIS DOCUMENT EACH PARTY REPRESENTS AND AGREES THAT: (A) THIS WRITTEN AGREEMENT REPRESENTS THE FINAL AGREEMENT BETWEEN THE PARTIES, (B) THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES, AND (C) THIS WRITTEN AGREEMENT MAY NOT BE CONTRADICTED BY EVIDENCE OF ANY PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OR UNDERSTANDINGS OF THE PARTIES.
8.COUNTERSIGNATURE. This Amendment shall become effective only when executed by Lender and Borrower.
[Signature Page Follows].
2



IN WITNESS WHEREOF, Borrower and Lender have executed this Agreement on the day and year above written.

BORROWER:
CHROMADEX CORPORATION, A DELAWARE CORPORATION


By /s/ Brianna Gerber
Name: Brianna Gerber
Title: Chief Financial Officer

CHROMADEX, INC., A CALIFORNIA CORPORATION


By/s/ Brianna Gerber
Name: Brianna Gerber
Title: Chief Financial Officer

CHROMADEX ANALYTICS, INC., A NEVADA CORPORATION


By/s/ Brianna Gerber
Name: Brianna Gerber
Title: Chief Financial Officer
Address for Notices:
c/o Chromadex Corporation
10900 Wilshire Blvd., Suite 600
Los Angeles, California 90024
Email:
Attn: Brianna Gerber, Chief Financial Officer


[Signature Page to Fourth Modification to Business Financing Agreement]


LENDER:
WESTERN ALLIANCE BANK, AN ARIZONA CORPORATION
By/s/ Timothy Carstens
Name: Timothy Carstens
Title: Managing Director, Head of Capital Finance
Address for Notices:
Western Alliance Bank
2700 W Sahara Ave
Las Vegas, Nevada 89102
Attn: Matthew Trusiak
Email:



[Signature Page to Fourth Modification to Business Financing Agreement]
EX-10.2 3 ex102-fifthmodificationtob.htm EX-10.2 Document
EXHIBIT 10.2
FIFTH MODIFICATION TO BUSINESS FINANCING AGREEMENT
This Fifth Modification to Business Financing Agreement (this “Amendment”) is entered into as of December 8, 2023, by and among WESTERN ALLIANCE BANK, an Arizona corporation (“Lender”), CHROMADEX CORPORATION, a Delaware corporation, CHROMADEX, INC., a California corporation, and CHROMADEX ANALYTICS, INC., a Nevada corporation (individually and collectively, “Borrower”).
1.DESCRIPTION OF EXISTING INDEBTEDNESS: Among other indebtedness which may be owing by Borrower to Lender, Borrower is indebted to Lender pursuant to, among other documents, a Business Financing Agreement, dated November 12, 2019, by and among Borrower, HEALTHSPAN RESEARCH LLC, a Delaware limited liability company (“Released Borrower”) and Lender, as may be amended from time to time (the “Business Financing Agreement”). Pursuant to that certain Consent Agreement dated January 14, 2021, by and among Borrower, Lender, and Released Borrower, Released Borrower was released by Lender from its Obligations under the Business Financing Agreement and the other Loan Documents. Capitalized terms used without definition herein shall have the meanings assigned to them in the Business Financing Agreement.
Hereinafter, all indebtedness owing by Borrower to Lender shall be referred to as the “Indebtedness” and the Business Financing Agreement and any and all other documents executed by Borrower in favor of Lender shall be referred to as the “Existing Documents”.
2.DESCRIPTION OF CHANGE IN TERMS.
(a)Fees. Sections 2.2(a) and (b) of the Business Financing Agreement are hereby amended by deleting them in their entirety and replacing them with the following:
(a)    Revolving Termination Fee. In the event this Agreement is terminated prior to the first anniversary of the Fifth Modification Closing Date, Borrower shall pay the Revolving Termination Fee to Lender, provided, that, the Revolving Termination Fee shall be waived by Lender if the Credit Extensions are refinanced with Lender or Lender’s affiliates.
(b)    Revolving Facility Fee. Borrower shall pay the Revolving Facility Fee to Lender promptly on the Fifth Modification Closing Date and on the first (1st) year anniversary of the Fifth Modification Closing Date.
(b)Distributions. Section 4.7 of the Business Financing Agreement is hereby amended by deleting it in its entirety and replacing it with the following:
4.7    Not pay any dividends or make any other distribution or payment on account of or in redemption, retirement or purchase of any capital stock, or permit any of its subsidiaries to do so, other than (i) the conversion of Borrower’s capital stock, (ii) dividends payable in capital stock of Borrower, (iii) cash in lieu of fractional shares upon exercise or conversion of the capital stock of Borrower contemplated in clause (i) of this Section 4.7, (iv) as disclosed in Schedule 4.7 of the Disclosure Letter, and (v) repurchases of the capital stock of Borrower, provided that (a) the aggregate amount of such repurchases does not exceed Two Million Five Hundred Thousand Dollars ($2,500,000) during the term of this Agreement (unless Lender consents in writing in its sole discretion to repurchases in excess of such amount), (b) no Default or an Event of Default exists prior to each repurchase or would not exist after giving effect to such repurchase, and (c) Borrower has delivered to Lender ten (10) Business Days’ prior written notice of each repurchase.
1


(c)Financial Reporting.
(i)Section 4.14(e) of the Business Financing Agreement is hereby amended by deleting it in its entirety and replacing it with the following:
(e)    Financial projections covering the current fiscal year, specifying the assumptions used in creating the projections and setting forth calculations showing compliance with the financial covenants set forth in this Agreement, and an annual budget approved by the Board of Directors of Borrower. Annual projections and annual Board-approved budgets shall in any case be provided to Lender no later than seventy-five (75) days after the beginning of each fiscal year.
(ii)Section 4.14 of the Business Financing Agreement is hereby amended by adding a new section 4.14(k) immediately following Section 4.14(j) as follows:
(k)    Within fifteen (15) days of each Month End, copies of bank statements of Borrower’s and its Subsidiaries’ accounts maintained with institutions other than Lender.
(d)Deposit Accounts. Section 4.15 of the Business Financing Agreement is hereby amended by deleting it in its entirety and replacing it with the following:
4.15    On and after January 31, 2024, maintain at least seventy-five percent (75%) its and its subsidiaries’ primary depository relationship, including operating and deposit accounts, with Lender; provided, that, any accounts maintained outside of Lender shall be subject to a deposit account control agreement in favor of Lender and in form and substance satisfactory to Lender except for Borrower’s accounts maintained with Adyen, PayPal, Humboldt, Stripe or other merchant processors so long as Borrower transfers the entire balance with such merchant processors to an operating account with Lender on a weekly basis. Borrower and its subsidiaries will endeavor to utilize Lender’s International Banking Division for services offered by such division including, without limitation, services related to foreign currency wires, hedging, swaps, and letters of credit. Borrower shall not, without Lender’s prior written consent, maintain more than Two Million Dollars ($2,000,000) in the aggregate in accounts outside the United States.
(e)Financial Covenants. Sections 4.17(a) and (b) of the Business Financing Agreement are hereby amended by deleting them in their entirety and replacing them with the following:
(a)    Reserved.
(b)    Cash. Borrower shall maintain at all times on and after January 31, 2024, tested as of each Month End occurring on or after January 31, 2024, unrestricted and unencumbered cash at Lender equal to or greater than the product of (a) seventy-five percent (75%) multiplied by (b) the difference of (i) the cash and cash equivalents reflected on Borrower’s balance sheet, minus (ii) cash maintained in accounts outside of the United States in an amount not to exceed Two Million Dollars ($2,000,000).
(f)Amended Defined Terms. The following definitions set forth in Section 13.1 of the Business Financing Agreement are hereby amended by deleting them in their entirety and replacing them with the following:
Finance Charge Percentage” means a floating rate per year equal to the Prime Rate plus one percent (1.00%), plus an additional five percent (5.00%) during any period that an Event of Default has occurred and is continuing.
Maturity Date” means November 12, 2025 or such earlier date as Lender shall have declared the Obligations immediately due and payable pursuant to Section 7.2.


2



Prime Rate” means the greater of (i) eight and one quarter of one percent (8.25%) per year or (ii) the Prime Rate published in the Money Rates section of the Western Edition of The Wall Street Journal, or such other rate of interest publicly announced from time to time by Lender as its Prime Rate. Lender may price loans to its customers at, above, or below the Prime Rate. Any change in the Prime Rate shall take effect at the opening of business on the day specified in the public announcement of a change in the Prime Rate.
Streamline Period” is, on and after the Fifth Modification Closing Date, provided no Event of Default has occurred and is continuing, the period (a) commencing on the first day of the month following the day that Borrower provides to Lender a written report that Borrower has maintained a Quick Ratio as determined by Lender in its judgment, of greater than or equal to 1.15:1.00 (the “Streamline Threshold”), as of the three (3) most recent preceding Month Ends; and (b) terminating on the earlier to occur of (i) the occurrence of an Event of Default, or (ii) the first day thereafter in which Borrower fails to maintain the Streamline Threshold, as determined by Lender in its judgment. Upon the termination of a Streamline Period, Borrower must maintain the Streamline Threshold for two (2) consecutive Month Ends as determined by Lender in its judgment, prior to entering into a subsequent Streamline Period. Each such Streamline Period shall commence on the first day of the month following the date Lender determines, in its judgment, that the Streamline Threshold has been achieved.
(g)Additional Defined Terms. The following terms and their respective definitions are hereby added to Section 13.1 of the Business Financing Agreement in alphabetical order:
Fifth Modification Closing Date” means December 8, 2023.
Quick Ratio” means the aggregate of unrestricted cash, unrestricted marketable securities and receivables convertible into cash divided by total current liabilities (including the outstanding Advances).
(h)Deleted Defined Terms. The following terms and their respective definitions set forth in Annex 1 to the Credit Agreement are hereby deleted in their entirety: “Average EBDAS”, “EBDAS”, “Liquidity”, and “RML”.
(i)Streamline Period. Lender and Borrower acknowledge and agree that a Streamline Period shall be in effect as of the Fifth Modification Closing Date.
(j)Exhibit A (Compliance Certificate). The Compliance Certificate is amended in its entirety and replaced with the Compliance Certificate in the form of Exhibit A attached hereto.
3.CONSISTENT CHANGES. The Existing Documents are each hereby amended wherever necessary to reflect the changes described above.
4.NO DEFENSES OF BORROWER/GENERAL RELEASE. Borrower agrees that, as of this date, it has no defenses against the obligations to pay any amounts under the Indebtedness. Each Borrower (each, a “Releasing Party”) acknowledges that Lender would not enter into this Amendment without Releasing Party’s assurance that it has no claims against Lender or any of Lender’s officers, directors, employees or agents. Except for the obligations arising hereafter under this Amendment, each Releasing Party releases Lender, and each of Lender’s and entity’s officers, directors and employees from any known or unknown claims that Releasing Party now has against Lender of any nature, including any claims that Releasing Party, its successors, counsel, and advisors may in the future discover they would have now had if they had known facts not now known to them, whether founded in contract, in tort or pursuant to any other theory of liability, including but not limited to any claims arising out of or related to the Agreement or the transactions contemplated thereby. Releasing Party waives the provisions of California Civil Code section 1542, which states:
A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.

3



The provisions, waivers and releases set forth in this section are binding upon each Releasing Party and its shareholders, agents, employees, assigns and successors in interest. The provisions, waivers and releases of this section shall inure to the benefit of Lender and its agents, employees, officers, directors, assigns and successors in interest. The provisions of this section shall survive payment in full of the Obligations, full performance of all the terms of this Amendment and the Business Financing Agreement, and/or Lender’s actions to exercise any remedy available under the Business Financing Agreement or otherwise.
5.CONTINUING VALIDITY. Borrower understands and agrees that in modifying the existing Indebtedness, Lender is relying upon Borrower’s representations, warranties, and agreements, as set forth in the Existing Documents. Except as expressly modified pursuant to this Amendment, the terms of the Existing Documents remain unchanged and in full force and effect. Lender’s agreement to modifications to the existing Indebtedness pursuant to this Amendment in no way shall obligate Lender to make any future modifications to the Indebtedness. Nothing in this Amendment shall constitute a satisfaction of the Indebtedness. It is the intention of Lender and Borrower to retain as liable parties all makers and endorsers of Existing Documents, unless the party is expressly released by Lender in writing. No maker, endorser, or guarantor will be released by virtue of this Amendment. The terms of this paragraph apply not only to this Amendment, but also to any subsequent Business Financing Agreement modifications.
6.CONDITIONS PRECEDENT. The effectiveness of this Amendment is conditioned upon (i) the due execution and delivery to Lender of this Amendment by each party hereto, and (ii) payment by Borrower to Lender of the Revolving Facility Fee in the amount of $50,000.00 due in connection with the renewal of the Maturity Date.
7.NOTICE OF FINAL AGREEMENT. BY SIGNING THIS DOCUMENT EACH PARTY REPRESENTS AND AGREES THAT: (A) THIS WRITTEN AGREEMENT REPRESENTS THE FINAL AGREEMENT BETWEEN THE PARTIES, (B) THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES, AND (C) THIS WRITTEN AGREEMENT MAY NOT BE CONTRADICTED BY EVIDENCE OF ANY PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OR UNDERSTANDINGS OF THE PARTIES.
8.COUNTERSIGNATURE. This Amendment shall become effective only when executed by Lender and Borrower.
[Signature Page Follows].
4



IN WITNESS WHEREOF, Borrower and Lender have executed this Agreement on the day and year above written.

BORROWER:
CHROMADEX CORPORATION, A DELAWARE CORPORATION


By /s/ Brianna Gerber
Name: Brianna Gerber
Title: Chief Financial Officer

CHROMADEX, INC., A CALIFORNIA CORPORATION


By /s/ Brianna Gerber
Name: Brianna Gerber
Title: Chief Financial Officer

CHROMADEX ANALYTICS, INC., A NEVADA CORPORATION


By /s/ Brianna Gerber
Name: Brianna Gerber
Title: Chief Financial Officer
Address for Notices:
c/o Chromadex Corporation
10900 Wilshire Blvd., Suite 600
Los Angeles, California 90024
Email:
Attn: Brianna Gerber, Chief Financial Officer


[Signature Page to Fifth Modification to Business Financing Agreement]


LENDER:
WESTERN ALLIANCE BANK, AN ARIZONA CORPORATION
By /s/ Tim Carstens
Name: Timothy Carstens
Title: Managing Director, Head of Capital Finance
Address for Notices:
Western Alliance Bank
2700 W Sahara Ave
Las Vegas, Nevada 89102
Attn: Matthew Trusiak
Email:



[Signature Page to Fifth Modification to Business Financing Agreement]


EXHIBIT A

COMPLIANCE CERTIFICATE
TO:    WESTERN ALLIANCE BANK, an Arizona corporation (the “Lender”)
FROM:    CHROMADEX CORPORATION, CHROMADEX, INC., and CHROMADEX ANALYTICS, INC. (collectively, “Borrower”)

The undersigned authorized officer of Borrower hereby certifies that in accordance with the terms and conditions of the Business Financing Agreement among Borrower and Lender (the “Agreement”), (i) Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below and (ii) all representations and warranties of Borrower stated in the Agreement are true and correct in all material respects as of the date hereof. Attached herewith are the required documents supporting the above certification. The Officer further certifies that these are prepared in accordance with Generally Accepted Accounting Principles (GAAP) and are consistently applied from one period to the next except as explained in an accompanying letter or footnotes.
Please indicate compliance status by circling Yes/No under “Complies” column.
Reporting CovenantRequiredComplies
Monthly financial statements (consolidated)
with Compliance Certificate
Monthly within 30 days (quarterly within 45 days if no advances outstanding)
YesNo
Annual financial statements (CPA Audited)FYE within 180 daysYesNo
Bank statements for outside accounts
Monthly within 15 days
YesNo
Borrowing Base Certificates, A/R & A/P Agings, sales or billings journal, cash receipts report, deferred revenue report, and inventory report
Monthly within 15 days (quarterly within 45 days if no advances outstanding) and, when a Streamline Period is not in
Effect, at the date of each Advance (other than inventory reports)
YesNo
Board approved budget
FYE within 75 days and as
amended/updated
YesNo
Financial CovenantRequiredActualComplies
Unrestricted cash at Lender (monthly)
75% of cash on
balance sheet
____%YesNo
Streamline ThresholdRequiredActualComplies

Quick Ratio1.15:1.00____:1.00Yes
No









Exhibit A-1



Comments Regarding Exceptions: See Attached.
BANK USE ONLY
Received by:
Sincerely,AUTHORIZED SIGNER
CHROMADEX CORPORATIONDate:
Verified:
SIGNATUREAUTHORIZED SIGNER
Date:
TITLE
Compliance StatusYesNo
DATE

CHROMADEX, INC.
SIGNATURE
TITLE
DATE

CHROMADEX ANALYTICS, INC.
SIGNATURE
TITLE
DATE

Exhibit A-2

EX-101.SCH 4 cdxc-20231208.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 cdxc-20231208_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name EX-101.PRE 6 cdxc-20231208_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Dec. 08, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Dec. 08, 2023
Entity Registrant Name CHROMADEX CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-37752
Entity Tax Identification Number 26-2940963
Entity Address, Address Line One 10900 Wilshire Blvd.
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Los Angeles
Entity Address, State or Province CA
Entity Address, Postal Zip Code 90024
City Area Code (310)
Local Phone Number 388-6706
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol CDXC
Entity Emerging Growth Company false
Entity Central Index Key 0001386570
Amendment Flag false
XML 8 cdxc-20231208_htm.xml IDEA: XBRL DOCUMENT 0001386570 2023-12-08 2023-12-08 0001386570 false 8-K 2023-12-08 CHROMADEX CORPORATION DE 001-37752 26-2940963 10900 Wilshire Blvd. Suite 600 Los Angeles CA 90024 (310) 388-6706 false false false false Common Stock, par value $0.001 per share CDXC false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://chromadex.com/role/Cover Cover Cover 1 false false All Reports Book All Reports cdxc-20231208.htm cdxc-20231208.xsd cdxc-20231208_lab.xml cdxc-20231208_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cdxc-20231208.htm": { "nsprefix": "cdxc", "nsuri": "http://chromadex.com/20231208", "dts": { "inline": { "local": [ "cdxc-20231208.htm" ] }, "schema": { "local": [ "cdxc-20231208.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "cdxc-20231208_lab.xml" ] }, "presentationLink": { "local": [ "cdxc-20231208_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://chromadex.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cdxc-20231208.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cdxc-20231208.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r5" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://chromadex.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001628280-23-041428-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-23-041428-xbrl.zip M4$L#!!0 ( > C5<1U*%(EQ( "QT 1 8V1X8RTR,#(S,3(P."YH M=&WM/5ESVSC2[_,K\&EV9NPJDR(IR3IL:\N1Y8QW$MLE>2JI??D*)"$)&XK4 M *0M[:_?;O#013F4XD/.)"\1"; !]-V-!GSZS^G8(_=,2![X9R53-TKDG^W3 M_].TS^]Z'\A%X$1CYH>D(Q@-F4L>>#@BX8B13X'XPN\IN?5H. C$6-/45YU@ M,A-\. J)95B5M%?2*%IVS65VK='4ZH93T:H#MZY1QES-K#:,FEUM'#MU]VC8 MP!%!G]K"TP,Q+'/?XS[# M!9=#07V)ZZ$A(*0,BS TP]),JS0'HDGF+ &"9WT8W#\*QZQI1D.KF"D<')SG M3\KY4%']S&:S M69XBXN:+W@31K"RL.EN;Y'EP87RS_/GCA[XS8F.JK:YPNC;SI?E@J^K:\J@_ M/"LQ7_NS7P(",^JV3\

  •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end